Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond

This publication has 35 references indexed in Scilit:

• Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants
  AIDS, 2003
• Effects of Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy on Serotonergic Symptoms in Newborns and Cord Blood Monoamine and Prolactin Concentrations
  Archives of General Psychiatry, 2003
• Long-Term Mitochondrial Toxicity in HIV-Uninfected Infants Born to HIV-Infected Mothers
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
• The Ontogeny of Human Drug-Metabolizing Enzymes: Phase I Oxidative Enzymes
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• The Ontogeny of Human Drug-Metabolizing Enzymes: Phase II Conjugation Enzymes and Regulatory Mechanisms
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• Ontogeny of drug-metabolizing enzymes and its influence on the pathogenesis of adverse drug reactions in children
  Current Therapeutic Research, 2001
• Integrating genotype and phenotype information: an overview of the PharmGKB project
  The Pharmacogenomics Journal, 2001
• Birth outcomes following prenatal exposure to fluoxetine
  Biological Psychiatry, 2000
• Biochemical Toxicology of Chemical Teratogenesis
  Critical Reviews in Biochemistry and Molecular Biology, 1996
• Fetal Effects of Maternal Drug Exposure
  Annual Review of Pharmacology and Toxicology, 1991